13F-HR filed by Sofinnova Investments, Inc.
Sofinnova Investments, Inc. filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-14, with 51 holding rows worth $1,685,205,763.
- Accession
- 0001104659-23-020042
- Filer
- CIK 1631134
- Filed
- 2023-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A holdings report, 53 entries on the cover page, a total value of $1,685,205,763 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,685,205,763 with VALUE read as dollars as filed, 13F file number 028-18774. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 2,073,124 | $407,368,867 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 3,100,560 | $124,549,495 | dollars as filed | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 3,758,686 | $110,129,500 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 880,800 | $107,572,104 | dollars as filed | |
| SANOFI SA SPONSORED ADR | 80105N105 | ADR | 1,965,475 | $95,187,954 | dollars as filed | |
| CINCOR PHARMA INC | 17240Y109 | COM | 6,073,949 | $74,648,833 | dollars as filed | |
| Merck & Co.,Inc. | 58933Y105 | COM | 603,356 | $66,942,348 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 3,181,442 | $61,560,903 | dollars as filed | |
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 413,173 | $47,019,087 | dollars as filed | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 156,989 | $45,335,283 | dollars as filed | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 613,673 | $41,607,029 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 394,643 | $40,841,604 | dollars as filed | |
| REATA PHARMACEUTICALS INC | 75615P103 | CL A | 992,029 | $37,687,182 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 247,955 | $32,130,009 | dollars as filed | |
| CTI BIOPHARMA CORP | 12648L601 | COM | 4,606,527 | $27,685,227 | dollars as filed | |
| INHIBRX INC | 45720L107 | COM | 1,110,183 | $27,354,909 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 89,207 | $24,807,575 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 100,000 | $23,765,000 | dollars as filed | call |
| CYTOKINETICS INC | 23282W605 | COM NEW | 508,930 | $23,319,173 | dollars as filed | |
| CHINOOK THERAPEUTICS INC | 16961L106 | COM | 806,459 | $21,129,226 | dollars as filed | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 1,004,045 | $20,221,466 | dollars as filed | |
| PROMETHEUS BIOSCIENCES INC | 74349U108 | COM | 176,545 | $19,419,950 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 703,074 | $17,893,233 | dollars as filed | |
| ALIGN TECHNOLOGY INC COM | 016255101 | Stock | 83,100 | $17,525,790 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 2,000,776 | $17,426,759 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 140,678 | $15,930,377 | dollars as filed | |
| IVERIC BIO INC | 46583P102 | COM | 638,398 | $13,668,101 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 56,448 | $13,414,867 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 578,268 | $12,160,976 | dollars as filed | |
| Y-mAbs Therapeutics Inc | 984241109 | Common Stock | 2,194,278 | $10,708,077 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 474,530 | $8,622,210 | dollars as filed | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 1,686,154 | $8,363,324 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 593,561 | $7,366,092 | dollars as filed | |
| AGENUS INC | 00847G705 | COM NEW | 2,894,057 | $6,945,737 | dollars as filed | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 314,811 | $6,510,291 | dollars as filed | |
| GERON CORP | 374163103 | COM | 2,369,100 | $5,733,222 | dollars as filed | call |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 631,411 | $4,596,672 | dollars as filed | |
| GALERA THERAPEUTICS EQUICLASS EQUITY | 36338D108 | COMMON STOCK | 3,083,712 | $4,594,731 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 100,000 | $4,582,000 | dollars as filed | call |
| INOZYME PHARMA INC | 45790W108 | COM | 3,655,308 | $3,838,073 | dollars as filed | |
| NEXTCURE INC | 65343E108 | COM | 2,671,856 | $3,767,317 | dollars as filed | |
| NUCANA PLC | 67022C106 | ADR | 5,599,999 | $3,695,999 | dollars as filed | |
| BOLT BIOTHERAPEUTICS INC | 097702104 | COM | 2,754,437 | $3,580,768 | dollars as filed | |
| GERON CORP | 374163103 | COM | 1,459,589 | $3,532,205 | dollars as filed | |
| AGENUS INC | 00847G705 | COM NEW | 1,267,000 | $3,040,800 | dollars as filed | call |
| CTI BIOPHARMA CORP | 12648L601 | COM | 410,000 | $2,464,100 | dollars as filed | call |
| PDS BIOTECHNOLOGY CORP | 70465T107 | COM | 142,635 | $1,882,782 | dollars as filed | |
| Nucana PLC | GB00BYWYV | COMMON SHARES | 2,400,000 | $1,584,000 | dollars as filed | |
| ObsEva SA | H5861P103 | COM | 4,749,623 | $688,695 | dollars as filed | |
| SYNLOGIC INC | 87166L100 | COM | 574,972 | $436,979 | dollars as filed | |
| FUSION PHARMACEUTICALS INC | 36118A100 | COM | 117,099 | $368,862 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-23-020042 | this filing | 2023-02-14 | acceptance time not in the bulk data set |